ConductScience.org, home

Paper39985508

Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis.

Shah T and 19 others. JACC Cardiovasc Interv, 2025. Cited by 36 papers, by iCite.

Cite this record

ConductScience Library. Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis. Papers, record 39985508. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39985508

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis.
PubMed
Journal
JACC Cardiovasc Interv
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
9.84, provisional
iCite
Revised in PubMed
2026-07-17
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shah TTayyab
2Zhang ZZhiyuan
3Shah HHaashim
4Fanaroff ACAlexander C
5Nathan ASAshwin S
6Parise HHelen
7Lutz JJohn
8Sugeng LLissa
9Bellumkonda LLavanya
10Redfors BBjörn
11Omerovic EElmir
12Petrie MCMark C
13Vora ANAmit N
14Fiorilli PNPaul N
15Kobayashi TTaisei
16Ahmad YYousif
17Forrest JKJohn K
18Giri JSJay S
19Herrmann HCHoward C
20Lansky AJAlexandra J

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Sodium-Glucose Transporter 2 InhibitorsMajor topic
Aortic Valve StenosisMajor topic
Aortic ValveMajor topic
Humans
Male
Disease Progression
Female
Retrospective Studies
Aged
Time Factors
Treatment Outcome
Risk Factors
Severity of Illness Index
Aged, 80 and over
Middle Aged
Risk Assessment
Electronic Health Records

Source PubMed

Download CSV of topics

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
42977773Cardiovascular disease in diabetes mellitus: beyond atherosclerosis and heart failure.Nat Rev Endocrinol2026https://conductscience.org/library/papers/42977773PubMed
42955596Effects of SGLT2 inhibition on cardiac remodeling and heart failure development in aortic stenosis rats.Mol Biomed2026https://conductscience.org/library/papers/42955596PubMed
42936081Clinical Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors After Transcatheter Aortic Valve Replacement in Patients With Diabetes: A Global Retrospective Study.J Soc Cardiovasc Angiogr Interv2026https://conductscience.org/library/papers/42936081PubMed
42769931Sodium-Glucose Cotransporter-2 Inhibitors in Valvular Heart Disease: From Mechanistic Insights to Clinical Application.J Soc Cardiovasc Angiogr Interv2026https://conductscience.org/library/papers/42769931PubMed
42652758Sodium-Glucose Cotransporter 2 Inhibitors in Valvular Heart Disease: Cardiovascular Benefit, Valve-Specific Effects, and Evidence Gaps-A Structured Narrative Review.J Clin Med2026https://conductscience.org/library/papers/42652758PubMed
42284627Emerging Role of Sodium-Glucose Cotransporter-2 Inhibitors in Aortic Stenosis.JACC Basic Transl Sci2026https://conductscience.org/library/papers/42284627PubMed
42233563SGLT2 Inhibition as a Novel Therapeutic Strategy in Rheumatic Heart Disease.JACC Asia2026https://conductscience.org/library/papers/42233563PubMed
42136720Differential expression of GLP1R, PCSK9, and SGLT2 in human aortic versus mitral valve tissues: exploratory findings in calcific aortic valve disease.Front Cardiovasc Med2026https://conductscience.org/library/papers/42136720PubMed
41938341Characteristics, clinical outcomes and molecular mechanisms associated with severe diastolic dysfunction in aortic stenosis.J Mol Cell Cardiol Plus2026https://conductscience.org/library/papers/41938341PubMed
41906747Heart failure and tricuspid regurgitation: the role of SGLT2 inhibitors in improving outcomes.Eur Heart J Cardiovasc Pharmacother2026https://conductscience.org/library/papers/41906747PubMed
41746781Efficacy of SGLT2 Inhibitors on Clinical Outcomes After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.Endocrinol Diabetes Metab2026https://conductscience.org/library/papers/41746781PubMed
41711713Interplay between medical and interventional therapies in valvular heart disease and heart failure: an expert opinion paper.ESC Heart Fail2026https://conductscience.org/library/papers/41711713PubMed
41598653Assessing Potential Valve-Preserving Effects of SGLT2 Inhibitors in Degenerative Aortic Stenosis: A Propensity-Matched Study.J Clin Med2026https://conductscience.org/library/papers/41598653PubMed
41595617Next-Generation SGLT2 Inhibitors: Innovations and Clinical Perspectives.Biomedicines2025https://conductscience.org/library/papers/41595617PubMed
41545296Prognostic significance implications of aortic valve sclerosis in the development of aortic stenosis: a systematic review and meta-analysis.Open Heart2026https://conductscience.org/library/papers/41545296PubMed
41294151Human Plasma in Calcific Aortic Valve Disease: Not Simply a Depot of Biomarkers.J Am Heart Assoc2026https://conductscience.org/library/papers/41294151PubMed
41294140Detrimental Effect of Plasma From Patients With Severe Aortic Stenosis on Valvular Endothelial Cells: Role of Proinflammatory Cytokines and Factor Xa.J Am Heart Assoc2026https://conductscience.org/library/papers/41294140PubMed
41096081Association of SGLT2 Inhibitors with Mortality and Bioprosthesis Valve Failure After TAVR: A Propensity-Matched Cohort Study.J Clin Med2025https://conductscience.org/library/papers/41096081PubMed
41055791The use of SGLT2 inhibitors in older people: What is important?Aging Clin Exp Res2025https://conductscience.org/library/papers/41055791PubMed
40839906Subclinical Leaflet Thrombosis and Subclinical Aortic Valve Complex Thrombosis in TAVR.JACC Adv2025https://conductscience.org/library/papers/40839906PubMed

See all 25 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39985508

GET https://conductscience.org/api/papers/v1/39985508/cited_by?page=2